OCGN 8-K: Material agreement
Ocugen
Filed with the SEC on · accession 0001104659-26-124836
OCGN filed a 8-K (current report) with the SEC on Nov 10, 2026. Ocugen entered into an exclusive license agreement with Celairis Therapeutics Holdings Pty Ltd granting Celairis rights to develop and commercialize OCU400, a gene therapy for retinitis pigmentosa, in Australia and several Southeast Asian countries.
Summary of the filing
Ocugen entered into an exclusive license agreement with Celairis Therapeutics Holdings Pty Ltd granting Celairis rights to develop and commercialize OCU400, a gene therapy for retinitis pigmentosa, in Australia and several Southeast Asian countries. Ocugen will receive up to $7.1 million in upfront and milestone payments plus royalties and 50% of gross profits, while retaining sole manufacturing rights.
Key details
✦ Ask GOAX AI about this filing — what it means for OCGN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for OCGN?
Click hereFrequently asked questions
What did OCGN file with the SEC on Nov 10, 2026?
OCGN filed a 8-K (Material agreement). Ocugen entered into an exclusive license agreement with Celairis Therapeutics Holdings Pty Ltd granting Celairis rights to develop and commercialize OCU400, a gene therapy for retinitis pigmentosa, in Australia and several Southeast Asian countries. Ocugen will receive up to $7.1 million in upfront and milestone payments plus royalties and 50% of gross profits, while retaining sole manufacturing rights.
What does a material agreement mean for OCGN stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other OCGN SEC filings
Get alerts when OCGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days